Compiled by Rupeestop LLP, SEBI RIA INA000022701. NAV as on 18 Aug 2026. Factsheet Jun 2026. About · Disclosures
SBI Healthcare Opportunities Fund Direct Growth
SBI Mutual FundSectoral Pharma and HealthcareDirectGrowthVery high risk
NAV
₹603.3454
As on 18 Aug 2026
Vs category
| Period | This fund | Category | Rank |
|---|---|---|---|
| 1 year | +21.36% | — | — |
| 3 year | +24.65% | — | — |
| 5 year | +19.53% | — | — |
- Sharpe
- 1.22
- Std dev
- 14.81%
- Beta
- 0.86
Returns
From NAVs through 18 Aug 2026
1Y
+21.36%
Total
3Y
+24.65%
p.a.
5Y
+19.53%
p.a.
SI
+18.72%
p.a.
Calendar years
-5.01%2022
+39.72%2023
+43.75%2024
-2.50%2025
+24.44%2026 YTD
Rolling 1-year · 51 overlapping windows
-11.78%avg +20.32%+62.91%
Fund facts
Fund details from the Jun 2026 factsheet
Fund size
₹4,997.72 Cr
Expense ratio
0.91%
Exit load
None
Lock-in
None
BenchmarkBSE Healthcare TRI
Launched01 Jan 2013
Risk levelVery high
StructureOpen Ended
Entry loadNone
ISININF200K01UP2
Where the money is invested
Split by asset type.
By asset type
Equity97.17%
Cash2.77%
Bonds0.06%
What the fund holds
35 holdings · portfolio as on 29 Jun 2026
- 11.18%Sun Pharmaceuticals Industries LtdHealthcare
- 6.35%Acutaas Chemicals LtdBasic Materials
- 5.92%Divi's Laboratories LtdHealthcare
- 5.21%Apollo Hospitals Enterprise LtdHealthcare
- 5.08%Max Healthcare Institute Ltd Ordinary SharesHealthcare
- 4.17%Aurobindo Pharma LtdHealthcare
- 3.77%Aster DM Healthcare Ltd Ordinary SharesHealthcare
- 3.64%Laurus Labs LtdHealthcare
- 3.52%Cipla LtdHealthcare
- 3.33%Torrent Pharmaceuticals LtdHealthcare
Concentration
Top 5 weight
33.75%
Top 10 weight
52.18%
Avg turnover
43.33%
Risk and quality measures
How steady the returns have been.
Return quality
Sharpe
1.22
Better than category avg 0.98
Sortino
2.02
Return per unit of downside risk
Alpha
3.18
Return above the benchmark
Information ratio
0.08
Consistency of outperformance
Risk
Std deviation
14.81%
How much returns swing
Beta
0.86
Better than category avg 0.95
R-squared
96.3%
How closely it tracks the benchmark
Who manages this fund
1 fund manager
- TDTanmaya Desai14.7 years in the industryRuns 3 schemes
Other Sectoral Pharma and Healthcare funds
ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan Growth-InsureddirectCompare
HDFC Pharma and Healthcare Fund Direct Plan IDCW ReinvestmentdirectCompare- ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan IDCW PayoutdirectCompare
Bandhan Healthcare FunddirectCompare- Bandhan BSE Healthcare Index Fund - Direct Plan - GrowthdirectCompare
DSP Nifty Healthcare ETF-Direct PlandirectCompare
Mirae Asset Nifty 500 Healthcare ETFdirectCompare
PGIM India Healthcare Fund Direct Plan - GrowthdirectCompare
SIP illustration
Rate
+24.65%
Invested
₹6,00,000
Illustrated
₹26,01,752
₹5,000/mo × 10 years at this fund's 3Y CAGR. Illustration, not a forecast. SIP calculator
Other versions
- regularIDCWSBI Healthcare Opportunities Fund Regular IDCW PayoutNAV ₹270.6122
- directIDCWSBI Healthcare Opportunities Fund Direct IDCW PayoutNAV ₹343.1053
- regularGrowthSBI Healthcare Opportunities Fund Regular GrowthNAV ₹429.5793
FAQ
What is SBI Healthcare Opportunities Fund Direct Growth NAV today?
- The latest NAV of SBI Healthcare Opportunities Fund Direct Growth is ₹603.3454 as on 18 Aug 2026.
How has SBI Healthcare Opportunities Fund Direct Growth performed vs its category?
- 1-year return +21.36%. Past performance does not guarantee future returns.
What are the returns of SBI Healthcare Opportunities Fund Direct Growth?
- Trailing returns from published NAVs: 1 year +21.36%, 3 year +24.65% a year, 5 year +19.53% a year, since our first NAV +18.72% a year. Past performance does not guarantee future returns.
How would a SIP in SBI Healthcare Opportunities Fund Direct Growth have been illustrated?
- The SIP illustration on this page uses ₹5,000 a month for 10 years at this fund's 3-year annualised return of +24.65%. It is not a forecast.
What is the expense ratio and fund size of SBI Healthcare Opportunities Fund Direct Growth?
- For SBI Healthcare Opportunities Fund Direct Growth, the expense ratio is 0.91% and fund size (AUM) is ₹4,997.72 Cr.
What is the ISIN of SBI Healthcare Opportunities Fund Direct Growth?
- The ISIN for SBI Healthcare Opportunities Fund Direct Growth is INF200K01UP2.
Mutual fund investments are subject to market risks. Read all scheme related documents carefully before investing. Past performance does not guarantee future returns and is not an indicator of future results.
Figures on this page come from published NAVs and the scheme's monthly factsheet. They are for information only and are not investment advice or a recommendation to buy or sell any scheme.